Loading stock data…
WRBY
$23.08+0.96 (+4.34%)
Market ClosedLast close May 1
Warby Parker Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Warby Parker Inc. in the Healthcare sector is trading at $23.08. The stock is currently 26% below its 52-week high of $31.00, remaining 3.3% below its 200-day moving average. Technical signals show neutral RSI of 57 and bearish MACD signal, explaining why WRBY maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 57) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$23.08
Potential Downside
99.3%
Whystock Fair Value$0.16
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus12 analysts
Buy
Mean target$29.17+26.4%
Range$24.00 – $35.00
Fundamentals
Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tint...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.01B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
2458.00
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.08
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-2.51%
Volume
Today's trading volume
1.45M
Recent News
1 Consumer Stock with Impressive Fundamentals and 2 That Underwhelm
Retailers are adapting their business models as technology changes how people shop. But many seem to be moving too slowly as their demand is lagging, causing the industry to underperform the market - over the past six months, retail stocks' 2.1% return has fallen short of the S&P 500’s 4.1% gain.
Is Warby Parker’s New Sport Eyewear Line Reshaping the Investment Case for WRBY?
On 28 April 2026, Warby Parker Inc. launched Warby Parker Sport, a five-style performance eyewear collection made in Italy with flexible nylon frames, advanced polarized lenses, and both prescription and non-prescription options available online and in stores from US$195. The move extends Warby Parker’s reach into performance and sports eyewear, offering sport-specific lens tints and allowing customers to add Sport lenses to existing sun frames for greater customization. Next, we’ll examine...
2 Cash-Producing Stocks on Our Buy List and 1 We Ignore
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
What Warby Parker's Co-CEO Just Sold $2.5M of Stock Really Means
This direct-to-consumer eyewear company, known for its omnichannel model, reported a notable insider sale amid strong 1-year price gains.
New York dispensary brand execs on the nuances of cannabis financing
Finance chief Roy Cysner and CEO Paul Yau aim to grow their luxury cannabis brand, The Travel Agency, in a complex regulatory environment with limited access to traditional credit.